Skip to content

Nephrocare mHealth Project: Telemonitoring of Blood Pressure

Nephrocare mHealth: Improvement of Patient Empowerment and Self-management by the Use of Telemonitoring.

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03708666
Acronym
Nephrocare
Enrollment
79
Registered
2018-10-17
Start date
2017-06-01
Completion date
2018-06-30
Last updated
2018-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Blood Pressure, Chronic Kidney Diseases

Brief summary

The Nephrocare mHealth project supports patients with Chronic Kidney Disease with a mobile application and telemonitoring. The application includes the follow-up of blood pressure.

Detailed description

Patients that are included in the Nephrocare mHealth project send their blood pressure results through an app or online website. The clinical decision support system will alert the patient, as well as the general practitioner and the hospital when the blood pressure is too high or low. In addition the clinical decision support will calculate monthly averages and all the data are connected with the electronic patient files.

Interventions

OTHERTelemonitoring of blood pressure

Blood pressure monitoring at least once a week.

Sponsors

General Hospital Groeninge
CollaboratorOTHER
Universitaire Ziekenhuizen KU Leuven
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
PREVENTION
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Dutch-speaking * Signed and approved informed consent * Follow-up by nephrology at the University Hospitals Leuven or General Hospital Groeninge

Exclusion criteria

* No Dutch-speaking * Impaired cognitive condition or medically unstable

Design outcomes

Primary

MeasureTime frameDescription
Systolic and diastolic blood pressure under control6 monthsPercentage of patients with blood pressure within target limits

Secondary

MeasureTime frameDescription
Adaptations of treatment6 monthsPercentage of change in hypertension therapy

Countries

Belgium

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026